bat1308
mAbexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 17, 2020 (NCT05155722)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05109650 | Phase 1 | Dec 15, 2021 | Biothera, Scientia Clinical Research Limited Sydney |
| NCT05073484 | Phase 1 | Oct 29, 2021 | Biothera, University of Liverpool |
| NCT05155722 | Phase 1 | Sep 17, 2020 | Biothera, Henan Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biothera | For profit | 3 | 3 | 1 | 2020 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Scientia Clinical Research Limited Sydney | For profit | 1 | 0 | 1 | 2021 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1